Literature DB >> 221495

NAD-dependent ADP-ribosylation of arginine and proteins by Escherichia coli heat-labile enterotoxin.

J Moss, S Garrison, N J Oppenheimer, S H Richardson.   

Abstract

Escherichia coli heat-labile enterotoxin (labile toxin, LT) catalyzed the hydrolysis of NAD to ADP-ribose and nicotinamide and the ADP-ribosylation of arginine (Moss, J., and Richardson, S.H. (1978) J. Clin. Invest. 62, 281-285). Analysis of the product of the ADP-ribosylation of arginine by nuclear magnetic resonance spectroscopy indicated that the reaction was stereospecific and resulted in the formation of alpha-ADP-ribosyl-L-arginine. This reaction product rapidly anomerized to yield a mixture of the alpha and beta forms. In the presence of [adenine-U-14C]NAD, E. coli enterotoxin catalyzed the transfer of the radiolabel to proteins; the ADP-ribosylation of proteins was inhibited by arginine methyl ester, an alternative substrate. Digestion of the 14C-protein with snake venom phosphodiesterase released predominantly 5'-AMP. No product was obtained with a mobility similar to that of 2'-(5''-phosphoribosyl)-5'-AMP. This result is consistent with the covalent attachment by the enterotoxin of ADP-ribose rather than poly(ADP-ribose) to protein. Thus, LT is catalytically equivalent to choleragen, an enterotoxin of Vibrio cholerae, and activates adenylate cyclase through a similar stereospecific ADP-ribosylation reaction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221495

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Host cell cytotoxicity and cytoskeleton disruption by CerADPr, an ADP-ribosyltransferase of Bacillus cereus G9241.

Authors:  Nathan C Simon; James M Vergis; Avesta V Ebrahimi; Christy L Ventura; Alison D O'Brien; Joseph T Barbieri
Journal:  Biochemistry       Date:  2013-03-20       Impact factor: 3.162

2.  Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex.

Authors:  Toshiharu Tsurumura; Yayoi Tsumori; Hao Qiu; Masataka Oda; Jun Sakurai; Masahiro Nagahama; Hideaki Tsuge
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

3.  Evidence that feedback inhibition of NAD kinase controls responses to oxidative stress.

Authors:  Julianne H Grose; Lisa Joss; Sidney F Velick; John R Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

4.  Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation.

Authors:  J Moss; M Vaughan
Journal:  Mol Cell Biochem       Date:  1981-07-07       Impact factor: 3.396

5.  ADP-ribosylation in inner membrane of rat liver mitochondria.

Authors:  C Richter; K H Winterhalter; S Baumhüter; H R Lötscher; B Moser
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Regulation of NAD synthesis by the trifunctional NadR protein of Salmonella enterica.

Authors:  Julianne H Grose; Ulfar Bergthorsson; John R Roth
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

Review 7.  ADP-ribosylarginine hydrolases.

Authors:  T Takada; I J Okazaki; J Moss
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

Review 8.  NAD hydrolysis: chemical and enzymatic mechanisms.

Authors:  N J Oppenheimer
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

9.  Side chain specificity of ADP-ribosylation by a sirtuin.

Authors:  Kamau Fahie; Po Hu; Stephen Swatkoski; Robert J Cotter; Yingkai Zhang; Cynthia Wolberger
Journal:  FEBS J       Date:  2009-11-06       Impact factor: 5.542

10.  Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens iota-toxin.

Authors:  Hideaki Tsuge; Masahiro Nagahama; Masataka Oda; Shinobu Iwamoto; Hiroko Utsunomiya; Victor E Marquez; Nobuhiko Katunuma; Mugio Nishizawa; Jun Sakurai
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.